Higher Dose Anticoagulation Cannot Prevent Disease Progression in COVID-19 Patients: A Systematic Review and Meta-Analysis.

Biomedicines · 2022 · PMC9496532 · PMID 36140295

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the intermediate dose cohort, there was an association of a decreased number of thrombotic events in the HD group, but this did not reach statistical significance (OR 0.71 [95% CI 0.13–4.00]).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.